If you’re living with Type 2 Diabetes you are not alone. Type 2 Diabetes affects over 30 million Americans. It’s a condition that tends to get worse over time and can lead to serious health complications, such as kidney damage, nerve damage, heart disease, and stroke.
If you are trying to control your blood sugar levels, you know how difficult this can be. Daily diabetes medications initially work well, but often become less effective over time. As the disease progresses, many people need increasing amounts and combinations of medications that can have side effects. Ultimately, this can lead to daily insulin injections and concerns about hypoglycemia.
Right now, doctors at select centers in the US are studying a new option that may be able to help. The ReCET Procedure is an investigational, non-surgical treatment designed to reduce blood sugar levels. The ReCET Procedure is currently being offered at no cost through the REGENT-1 US Study.
What is the ReCET Procedure?
The ReCET Procedure is an investigational, non-surgical treatment designed to reduce blood sugar levels.
Research shows that cells in the lining (mucosa) of the small intestine play an important role in controlling blood sugar levels. In people with type 2 diabetes, these cells may not function properly.
During an ReCET Procedure, while the patient is asleep, a doctor uses a small flexible camera to introduce a specialized device through the mouth and past the stomach to the first part of the small intestine, called the duodenum. The device is used to apply a precise, controlled, electric energy to the lining (mucosa) of the small intestine. This delivery of energy is designed to trigger the body’s natural process to regenerate healthy cells that help control blood sugar levels.
The ReCET Procedure is typically performed on an outpatient basis, with most people returning home the same day as their procedure.
The ReCET Procedure is currently only available in the US through the REGENT-1 US Clinical Study. If you qualify and choose to join the study, you will receive the ReCET Procedure and all study-related care at no cost.
If you’re living with Type 2 Diabetes and interested in a new way to potentially control your blood sugar, you may be a candidate for the REGENT-1 US Study. The study is for the ReCET Procedure - an investigational, non-surgical procedure designed to reduce blood sugar levels. If you qualify and choose to join the REGENT-1 US Study you will receive:
If you qualify and choose to join the study, you will receive:
See If You Qualify
To see if you might qualify for the REGENT-1 US Study, and to get connected with your local study center to learn more, please take the questionnaire below: